Abacavir | Reverse Transcriptase Inhibitor

Size	Price	VIP Price	US Stock	Global Stock	In Stock
{[ item.pr_size ]}		Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}			Login	- +	Inquiry

NCT02868580	Amyotrophic Lateral Sclerosis	Phase 2	Active, not recruiting	June 2018	Australia, New South Wales ... More >> Macquarie Neurology North Ryde, New South Wales, Australia, 2109 Westmead Hospital Parramatta, New South Wales, Australia, 2150 Brain and Mind Centre Sydney, New South Wales, Australia, 2050 Australia, Victoria Calvary Health Care Bethlehem Caulfield South, Victoria, Australia, 3162 Less <<
NCT00085943	HIV Infection ... More >> Infection, Human Immunodeficiency Virus Less <<	Phase 3	Completed	-	-
NCT00005017	HIV Infections	Phase 4	Unknown	-	United States, North Carolina ... More >> Jaime Hernandez Research Triangle Park, North Carolina, United States, 27709 Less <<
NCT02708342	-		Completed	-	-
NCT00724711	-		Completed	-	-
NCT00724711	HIV Infection	Phase 4	Completed	-	-
NCT02596334	HIV	Phase 3	Terminated(5 patients on tivic... More >>ay had virological failure) Less <<	-	France ... More >> CHD de VENDEE La Roche sur Yon, France, 85925 CH de LA ROCHELLE La Rochelle, France, 17019 CHRU de NANTES Nantes, France, 44093 CH de NIORT Niort, France, 79021 CHR d'ORLEANS Orleans, France, 45032 CHRU de POITIERS Poitiers, France, 86021 CHU de STRASBOURG Strasbourg, France, 67000 CHRU de TOURS Tours, France, 37044 CHU de NANCY Vandoeuvre Les Nancy, France, 54511 Less <<
NCT02342769	-		Active, not recruiting	October 15, 2018	Germany ... More >> GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Mannheim, Baden-Wuerttemberg, Germany, 68161 GSK Investigational Site Stuttgart, Baden-Wuerttemberg, Germany, 70197 GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89081 GSK Investigational Site Muenchen, Bayern, Germany, 80331 GSK Investigational Site Muenchen, Bayern, Germany, 80336 GSK Investigational Site Muenchen, Bayern, Germany, 80801 GSK Investigational Site Frankfurt am Main, Hessen, Germany, 60590 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Osnabrueck, Niedersachsen, Germany, 49090 GSK Investigational Site Aachen, Nordrhein-Westfalen, Germany, 52062 GSK Investigational Site Duesseldorf, Nordrhein-Westfalen, Germany, 40237 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 50674 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55116 GSK Investigational Site Magdeburg, Sachsen-Anhalt, Germany, 39120 GSK Investigational Site Berlin, Germany, 10243 GSK Investigational Site Berlin, Germany, 10405 GSK Investigational Site Berlin, Germany, 10707 GSK Investigational Site Berlin, Germany, 10777 GSK Investigational Site Berlin, Germany, 10961 GSK Investigational Site Berlin, Germany, 13347 GSK Investigational Site Berlin, Germany, 14057 GSK Investigational Site Chemnitz, Germany, 09111 GSK Investigational Site Dortmund, Germany, 44137 GSK Investigational Site Hamburg, Germany, 20099 GSK Investigational Site Hamburg, Germany, 20246 GSK Investigational Site Koeln, Germany, 50668 GSK Investigational Site Koeln, Germany, 50679 GSK Investigational Site Weimar, Germany, 99427 Less <<
NCT00002199	HIV Infections	Phase 3	Completed	-	United States, Massachusetts ... More >> Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 Less <<
NCT00086359	HIV Infections	Phase 3	Completed	-	United States, California ... More >> Usc La Nichd Crs Los Angeles, California, United States, 90033 UCSD Mother-Child-Adolescent Program CRS San Diego, California, United States, 92103 United States, Florida Univ. of Miami Ped. Perinatal HIV/AIDS CRS Miami, Florida, United States, 33136 United States, Illinois Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program Chicago, Illinois, United States, 60608 United States, New York Bronx-Lebanon CRS Bronx, New York, United States, 10457 United States, Tennessee Regional Med. Ctr. at Memphis Memphis, Tennessee, United States, 38105-2794 United States, Texas Texas Children's Hosp. CRS Houston, Texas, United States, 77030 Puerto Rico San Juan City Hosp. PR NICHD CRS San Juan, Puerto Rico Less <<
NCT00004981	HIV Infections	Phase 3	Unknown	-	United States, California ... More >> AIDS Healthcare Foundation Los Angeles, California, United States, 900276069 Tower Infectious Disease Med Ctr Los Angeles, California, United States, 90048 Robert Scott MD Oakland, California, United States, 94609 St Lukes Medical Group San Diego, California, United States, 92101 United States, District of Columbia Georgetown Univ Med Ctr Washington, District of Columbia, United States, 20007 Whitman Walker Clinic Washington, District of Columbia, United States, 20009 United States, Florida Univ of Miami School of Medicine Miami, Florida, United States, 33136 Specialty Med Care Ctrs of South Florida Inc Miami, Florida, United States, 33142 Saint Josephs Comprehensive Research Institute Tampa, Florida, United States, 33607 United States, Georgia AIDS Research Consortium of Atlanta Atlanta, Georgia, United States, 30308 United States, Illinois Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States, 60612 United States, Massachusetts New England Med Ctr Boston, Massachusetts, United States, 02111 United States, Missouri Research Med Ctr Kansas City, Missouri, United States, 64111 United States, New York Addiction Research and Treatment Corp Brooklyn, New York, United States, 11201 Saint Vincent's Hosp and Med Ctr New York, New York, United States, 10011 St Luke Roosevelt Hosp New York, New York, United States, 10011 United States, Pennsylvania Lehigh Valley Hosp Allentown, Pennsylvania, United States, 18105 Hahnemann Univ Hosp Philadelphia, Pennsylvania, United States, 191021192 Anderson Clinical Research Pittsburgh, Pennsylvania, United States, 15213 United States, South Carolina Burnside Clinic Columbia, South Carolina, United States, 29206 United States, Tennessee Univ of Tennessee Memphis, Tennessee, United States, 38163 Nashville Health Management Foundation / Vanderbilt Univ Nashville, Tennessee, United States, 37203 United States, Texas Nicholas Bellos Dallas, Texas, United States, 75246 Univ of Texas Med Branch Galveston, Texas, United States, 77555 Therapeutic Concepts Houston, Texas, United States, 77004 Less <<
NCT00118898	-		Completed	-	-
NCT00118898	HIV Infections	Phase 3	Completed	-	-
NCT00998582	-		Terminated(Low enrollment)	-	-
NCT00998582	HIV Infections	Phase 4	Terminated(Low enrollment)	-	United States, Minnesota ... More >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Abbott Northwestern Hospital and Clinics Minneapolis, Minnesota, United States Less <<
NCT00549198	-		Completed	-	-
NCT00139178	HIV Associated Lipodystrophy S... More >>yndrome. HIV Hypercholesterolemia Lipoatrophy Less <<	Phase 4	Completed	-	Denmark ... More >> Department of Infectious Diseases, Aarhus University Hospital Aarhus, Denmark, 8200 Department of Infectious Diseases, Rigshospitalet Copenhagen, Denmark, 2100 Department of Infectious Diseases, Hvidovre University Hospital Hvidovre, Denmark, 2650 Department of Infectious diseases, Odense University Hospital Odense, Denmark, 5000 Less <<
NCT00002213	HIV Infections	Phase 2	Completed	-	United States, California ... More >> East Bay AIDS Ctr Berkeley, California, United States, 94705 Kraus Med Partners Los Angeles, California, United States, 90036 United States, Illinois Northwestern Univ Med School AIDS Treatment Unit Chicago, Illinois, United States, 60611 United States, Maryland Niaid / Nih Bethesda, Maryland, United States, 20892 United States, Massachusetts Beth Israel Deaconess Med Ctr Boston, Massachusetts, United States, 02215 United States, New York Saint Vincents Hosp / AIDS Ctr / 4th Floor New York, New York, United States, 10011 United States, North Carolina Univ of North Carolina Chapel Hill Chapel Hill, North Carolina, United States, 27499 United States, Ohio Univ Int Med Assoc Inc / Holmes Hosp / U of Cincinnati Cincinnati, Ohio, United States, 45267 United States, Rhode Island The Miriam Hosp Providence, Rhode Island, United States, 02906 Less <<
NCT03316534	HIV-infected Patients	Phase 2	Completed	-	-
NCT00038506	HIV Infection	Phase 4	Completed	-	United States, California ... More >> GSK Investigational Site Los Angeles, California, United States, 90027 GSK Investigational Site San Rafael, California, United States, 94903 United States, Florida GSK Investigational Site Fort Lauderdale, Florida, United States, 33145 GSK Investigational Site Jacksonville, Florida, United States, 32206 GSK Investigational Site Lake Worth, Florida, United States, 33463 GSK Investigational Site Miami Beach, Florida, United States, 33139 GSK Investigational Site Miami, Florida, United States, 33136 GSK Investigational Site North Miami, Florida, United States, 33161 GSK Investigational Site Orlando, Florida, United States, 32804 GSK Investigational Site Tallahassee, Florida, United States, 32303 United States, Georgia GSK Investigational Site Atlanta, Georgia, United States, 30309 GSK Investigational Site Decatur, Georgia, United States, 30033 United States, Illinois GSK Investigational Site Chicago, Illinois, United States, 60657 GSK Investigational Site Maywood, Illinois, United States, 60153 United States, Indiana GSK Investigational Site Lafayette, Indiana, United States, 47904 United States, Michigan GSK Investigational Site Berkeley, Michigan, United States, 48072 United States, New York GSK Investigational Site Bronx, New York, United States, 10461 GSK Investigational Site New York, New York, United States, 10014 GSK Investigational Site Valhalla, New York, United States, 10595 United States, Oklahoma GSK Investigational Site Tulsa, Oklahoma, United States, 74114 United States, Texas GSK Investigational Site Arlington, Texas, United States, 76015 GSK Investigational Site Dallas, Texas, United States, 75208 GSK Investigational Site Dallas, Texas, United States, 75216 GSK Investigational Site Dallas, Texas, United States, 75246 GSK Investigational Site Houston, Texas, United States, 77004 United States, Washington GSK Investigational Site Seattle, Washington, United States, 98104 United States, Wisconsin GSK Investigational Site Green Bay, Wisconsin, United States, 54301 Less <<
NCT00549198	Infection, Human Immunodeficie... More >>ncy Virus I HIV Infection Less <<	Phase 4	Completed	-	-
NCT00002391	HIV Infections	Phase 3	Completed	-	-
NCT00002389	HIV Infections	Phase 3	Completed	-	United States, California ... More >> East Bay AIDS Ctr Berkeley, California, United States, 94705 Kraus Med Partners Los Angeles, California, United States, 90036 United States, District of Columbia Georgetown Univ Med Ctr Washington, District of Columbia, United States, 20007 United States, Florida Univ of Miami Dept of Medicine Miami, Florida, United States, 33136 United States, Illinois Rush Med College / Rush Presbyterian - St Luke's Med Cen Chicago, Illinois, United States, 60612 United States, Massachusetts Boston Med Ctr / Evans - 556 Boston, Massachusetts, United States, 021182393 United States, New Jersey Saint Michael's Med Ctr / Dept of Infectious Diseases Newark, New Jersey, United States, 07102 United States, New York St Vincent's Hosp and Med Ctr / AIDS Ctr New York, New York, United States, 10011 Harlem Hosp New York, New York, United States, 10027 United States, North Carolina Duke Univ Med Ctr / Dept of Medicine Durham, North Carolina, United States, 27710 United States, Ohio Univ of Cincinnati / Holmes Hosp Cincinnati, Ohio, United States, 452670405 United States, Texas Dr Nicholaos Bellos Dallas, Texas, United States, 75225 Baylor College of Medicine / Dept of Medicine Houston, Texas, United States, 770303498 Canada, Ontario Toronto Gen Hosp Toronto, Ontario, Canada Puerto Rico San Juan AIDS Program Santurce, Puerto Rico, 00907 Less <<
NCT02246998	HIV-1 Infection	Phase 4	Completed	-	Belgium ... More >> Brussels, Belgium Ghent, Belgium France Lyon, France Paris, France Rennes, France Tourcoing, France Ireland Dublin, Ireland Spain Barcelona, Spain Madrid, Spain Seville, Spain United Kingdom Birmingham, United Kingdom Bournemouth, United Kingdom Brighton, United Kingdom Bristol, United Kingdom Coventry, United Kingdom Liverpool, United Kingdom London, United Kingdom Manchester, United Kingdom Newcastle, United Kingdom Sheffield, United Kingdom Less <<
NCT00426296	HIV Infections ... More >> Lipodystrophy Less <<	Phase 4	Unknown	-	United States, District of Col... More >>umbia Whitman-Walker Clinic Recruiting Washington, District of Columbia, United States Contact: Richard Elion, MD drrelion@aol.com Principal Investigator: Richard A Elion, MD Less <<
NCT00084149	-		Completed	-	-
NCT02246998	-		Completed	-	-
NCT02603107	HIV-1 Infection	Phase 3	Active, not recruiting	July 2020	-
NCT00865007	HIV Infection ... More >> Lipodystrophy HIV Infections Less <<	Phase 4	Completed	-	Spain ... More >> Hospital Severo Ochoa Leganes, Madrid, Spain, 28911 Hospital Xeral Cies Vigo, Pontevedra, Spain, 36204 Hospital de Donostia Donostia, San Sebastian, Spain, 20014 Hospital de Basurto Bilbao, Vizcaya, Spain, 48013 Hospital General Universitario de Alicante Alicante, Spain, 03010 Hospital Sant Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clinico y Provincial Barcelona, Spain, 08036 Hospital Universitario Reina Sofia Cordoba, Spain, 14004 Hospital La Paz Madrid, Spain, 28006 Hospital Doce de Octubre Madrid, Spain, 28041 Hospital La Paz Madrid, Spain, 28046 Less <<
NCT00084149	HIV Infections	Phase 2	Completed	-	United States, Minnesota ... More >> University of Minnesota, ACTU Minneapolis, Minnesota, United States, 55455-0392 United States, New York Beth Israel Med. Ctr., ACTU New York, New York, United States, 10003 NY Univ. HIV/AIDS CRS New York, New York, United States, 10016-6481 United States, Ohio MetroHealth CRS Cleveland, Ohio, United States, 44109-1998 Less <<
NCT02607930	HIV-1 Infection	Phase 3	Active, not recruiting	April 2020	-
NCT02607930	-		Active, not recruiting	-	-
NCT00006617	HIV Infections	Not Applicable	Completed	-	United States, New York ... More >> Aaron Diamond AIDS Res Ctr New York, New York, United States, 10016 Less <<
NCT01910402	Infection, Human Immunodeficie... More >>ncy Virus Less <<	Phase 3	Active, not recruiting	December 31, 2020	-
NCT02603107	-		Active, not recruiting	-	-
NCT00002419	HIV Infections	Phase 2	Completed	-	United States, California ... More >> Pacific Oaks Med Group Beverly Hills, California, United States, 90211 United States, Colorado Univ of Colorado / Health Science Ctr Denver, Colorado, United States, 80262 United States, Georgia AIDS Research Consortium of Atlanta Atlanta, Georgia, United States, 30308 United States, Rhode Island Brown Univ School of Medicine Providence, Rhode Island, United States, 02908 United States, Virginia Hampton Roads Med Specialists Hampton, Virginia, United States, 23666 Less <<
NCT00009061	HIV Infections	Phase 3	Unknown	-	-
NCT01982396	HIV Infection	Phase 1	Completed	-	United Kingdom ... More >> Great Ormond Street Hospital London, United Kingdom St. Mary's Hospital London, United Kingdom Less <<
NCT03685500	HIV Infections	Phase 4	Not yet recruiting	December 15, 2019	Spain ... More >> Hospital Puerta de Hierro Not yet recruiting Majadahonda, Madrid, Spain Contact: Alfonso Angel-Moreno Maroto 911 916 112 alfangel22@hotmail.com Hospital Fundación Jimenez Diaz Not yet recruiting Madrid, Spain Contact: Alfonso Cabello 915504800 ext 4055 acabello@fjd.es Hospital Infanta Leonor Not yet recruiting Madrid, Spain Contact: Jesus Troya, MD jestrogar@hotmail.com Hospital Universitario La Paz Not yet recruiting Madrid, Spain Contact: Ignacio Perez valero, MD 0034917277000 ext 42132 ignacioperezvalero@gmail.com Less <<
NCT00011895	HIV Infections	Phase 4	Unknown	-	-
NCT00337922	HIV Infection	Phase 4	Completed	-	Japan ... More >> GSK Investigational Site Nagano, Japan, 384-0301 GSK Investigational Site Osaka, Japan, 540-0006 GSK Investigational Site Shizuoka, Japan, 432-8002 GSK Investigational Site Tokyo, Japan, 162-0052 Less <<
NCT02120352	Infection, Human Immunodeficie... More >>ncy Virus Less <<	Phase 2	Active, not recruiting	December 31, 2020	-
NCT02893488	Infection, Human Immunodeficie... More >>ncy Virus Less <<	Phase 1	Completed	-	United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT00002239	HIV Infections	Phase 2	Completed	-	United States, California ... More >> Pacific Oaks Research Beverly Hills, California, United States, 90211 UCLA Care Ctr Los Angeles, California, United States, 90095 ViRx Inc Palm Springs, California, United States, 92262 Donald Northfelt Palm Springs, California, United States, 92270 UCSD San Diego, California, United States, 92103 ViRx Inc San Francisco, California, United States, 94109 Quest Clinical Research San Francisco, California, United States, 94115 United States, District of Columbia Dupont Circle Physicians Group Washington, District of Columbia, United States, 200091104 United States, Florida IDC Research Initiative Altamonte Springs, Florida, United States, 32701 Gary Richmond MD Fort Lauderdale, Florida, United States, 33316 United States, Georgia AIDS Research Consortium of Atlanta Atlanta, Georgia, United States, 30308 United States, Maryland Johns Hopkins Hosp Baltimore, Maryland, United States, 21287 United States, Missouri Washington Univ School of Medicine St. Louis, Missouri, United States, 63110 United States, New York New York Univ Med Ctr New York, New York, United States, 10016 United States, North Carolina Trimeris Inc Durham, North Carolina, United States, 27707 United States, Oklahoma Associates of Med and Mental Health Tulsa, Oklahoma, United States, 74114 United States, Pennsylvania Pennsylvania Oncology and Hematology Associates Philadelphia, Pennsylvania, United States, 19106 Philadelphia FIGHT Philadelphia, Pennsylvania, United States, 19107 Univ of Pittsburgh Pittsburgh, Pennsylvania, United States, 15261 United States, Texas Central Texas Clinical Research Austin, Texas, United States, 78705 Less <<
NCT01910402	-		Active, not recruiting	-	-
NCT00001132	HIV Infections	Phase 2	Completed	-	-
NCT02539576	Infection, Human Immunodeficie... More >>ncy Virus Less <<	Phase 1	Completed	-	United States, California ... More >> GSK Investigational Site Glendale, California, United States, 91206 Less <<
NCT00002364	HIV Infections	Phase 2	Completed	-	United States, California ... More >> Marin County Specialty Clinic Greenbrae, California, United States, 94904 Kraus Med Partners Los Angeles, California, United States, 90036 ViRx Inc San Francisco, California, United States, 94109 United States, Florida IDC Research Initiative Altamonte Springs, Florida, United States, 32701 North Broward Hosp District Fort Lauderdale, Florida, United States, 33316 United States, Georgia AIDS Research Consortium of Atlanta Atlanta, Georgia, United States, 30308 United States, Kentucky Univ of Kentucky Med Ctr Lexington, Kentucky, United States, 40536 United States, New York Beth Israel Med Ctr New York, New York, United States, 10003 Less <<
NCT00338390	HIV Infections	Phase 3	Completed	-	Spain ... More >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Hospital Sant Jaume de Calella Calella, Barcelona, Spain, 08370 Hospital de Mataró Mataro, Barcelona, Spain, 08304 Hospital Basurto Bilbao, Bilabao, Spain, 48013 H. del S.A.S. Jerez de la Frontera Jerez de la Frontera, Cádiz, Spain, 11407 Fundació Hospital de Granollers, Barcelona, Granollers, Spain, 08400 Hospital Arquitecto Marcide El Ferrol, La Coruña, Spain, 15405 Hospital Sierrallana Torrelavega, Santander, Spain, 39300 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Clínic de Barcelona Barcelona, Spain, 08036 Hospital General de Castellón, , Castellón, Castello, Spain, 12004 H. San Fco Borja Gandia Gandia, Spain, 46700 Hospital de Cabueñes Gijon, Spain, 33394 Hospital Clínico San Cecílio Granada, Spain, 18012 Fundación Jiménez Diaz Madrid, Spain, 28040 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Marqués de Valdecilla Santander, Spain, 39008 Hospital Virgen Macarena Sevilla, Spain, 41009 Hospital Joan XXIII Tarragona, Spain, 43007 Hospital Arnau de Vilanova Valencia, Spain, 46015 Hospital Xeral de Vigo Vigo, Spain, 36204 Less <<
NCT00002362	HIV Infections	Phase 3	Suspended	-	United States, California ... More >> Ctr for AIDS Research / Education and Service (CARES) Sacramento, California, United States, 95814 San Francisco Veterans Administration Med Ctr San Francisco, California, United States, 94121 United States, Florida Gary Richmond MD Fort Lauderdale, Florida, United States, 33316 United States, Illinois Northstar Med Clinic Chicago, Illinois, United States, 60657 United States, New Jersey South Jersey Infectious Diseases Inc Somers Point, New Jersey, United States, 08244 United States, New York North Shore Univ Hosp / Div of Infectious Diseases Manhasset, New York, United States, 11030 United States, Texas Univ of Texas Southwestern Med Ctr of Dallas Dallas, Texas, United States, 75235 Houston Clinical Research Network Houston, Texas, United States, 77006 Univ of Texas / Med School at Houston Houston, Texas, United States, 77030 Univ of Texas Health Sciences Ctr San Antonio, Texas, United States, 78284 Less <<
NCT00002390	HIV Infections	Phase 2	Completed	-	France ... More >> Group Hospier Pitie-Salpetriere / Maladies Infec et Trop Paris Cedex 13, France Groupe Hospitalier Bichat-Claude Bernard Paris Cedex 18, France Hopital de Purpan / CHU de Rangueil / Medecine Interue Toulouse Cedex, France Hopital de Purpan / Service du Professeur Auvergnat Toulouse Cedex, France Germany Universitat Erlangen Erlangen, Germany Universitatsklinikurn Frankfurt Frankfurt, Germany Less <<
NCT00002388	HIV Infections	Phase 1	Completed	-	United States, Illinois ... More >> Evanston Hosp / Clinical Pharmacology Unit Evanston, Illinois, United States, 60201 United States, Massachusetts Fenway Community Health Ctr / Research Dept Boston, Massachusetts, United States, 02115 United States, New York Albany Med College / Albany Med Ctr Hosp Albany, New York, United States, 12208 Less <<
NCT00001086	HIV Infections	Phase 2	Completed	-	-
NCT00001758	HIV Infection	Phase 2	Completed	-	United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00647946	Lipodystrophy	Phase 2	Completed	-	United Kingdom ... More >> Gilead Sciences Abingdon, Cambridge, United Kingdom, CB1 6GT Less <<
NCT00094367	HIV Infection	Phase 3	Completed	-	-
NCT00002217	HIV Infections	Not Applicable	Completed	-	United States, Pennsylvania ... More >> Anderson Clinical Research Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02105987	Infection, Human Immunodeficie... More >>ncy Virus Less <<	Phase 3	Completed	-	-
NCT00002198	HIV Infections	Phase 1	Completed	-	United States, North Carolina ... More >> PPD Development, Inc Wilmington, North Carolina, United States, 28412 Less <<
NCT02105987	-		Completed	-	-
NCT00000864	HIV Infections	Phase 1	Completed	-	United States, Alabama ... More >> UAB, Dept. of Ped., Div. of Infectious Diseases Birmingham, Alabama, United States, 35233 United States, California Usc La Nichd Crs Los Angeles, California, United States, 90033 UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States, 900951752 UCSD Maternal, Child, and Adolescent HIV CRS San Diego, California, United States United States, Florida Univ. of Florida Jacksonville NICHD CRS Jacksonville, Florida, United States, 32209 United States, Georgia Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases Atlanta, Georgia, United States, 30306 United States, Illinois Univ. of Illinois College of Medicine at Chicago, Dept. of Peds. Chicago, Illinois, United States, 60612 United States, Massachusetts HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston, Massachusetts, United States, 021155724 United States, New York Bronx-Lebanon Hosp. IMPAACT CRS Bronx, New York, United States, 10457 SUNY Upstate Med. Univ., Dept. of Peds. Syracuse, New York, United States, 13210 United States, North Carolina DUMC Ped. CRS Durham, North Carolina, United States, 277103499 United States, South Carolina Med. Univ. of South Carolina, Div. of Ped. Infectious Diseases Charleston, South Carolina, United States, 294253312 Puerto Rico San Juan City Hosp. PR NICHD CRS San Juan, Puerto Rico, 009367344 Less <<
NCT00373945	-		Completed	-	-
NCT00002163	AIDS Dementia Complex ... More >> HIV Infections Less <<	Phase 3	Completed	-	United States, California ... More >> HIV Neurobehavioral Research Ctr San Diego, California, United States, 92103 San Francisco Gen Hosp San Francisco, California, United States, 94110 United States, Maryland Johns Hopkins Univ School of Medicine Baltimore, Maryland, United States, 21287 United States, Missouri Washington Univ Med Ctr St Louis, Missouri, United States, 63110 United States, New York Mount Sinai Med Ctr New York, New York, United States, 10029 Columbia Univ / Sergievsky Ctr New York, New York, United States, 10032 United States, North Carolina Univ of North Carolina School of Medicine Chapel Hill, North Carolina, United States, 27599 Canada, Manitoba Univ of Manitoba / Faculty of Medicine Winnipeg, Manitoba, Canada Canada, Ontario Wellesley Hosp Toronto, Ontario, Canada Less <<
NCT00143702	Acidosis, Lactic	Phase 2 Phase 3	Completed	-	Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Canada, Ontario Positive Care Clinic Toronto, Ontario, Canada Less <<
NCT00002200	HIV Infections	Not Applicable	Completed	-	United States, North Carolina ... More >> Glaxo Wellcome Inc Research Triangle Park, North Carolina, United States, 277093398 Less <<
NCT00002197	HIV Infections	Not Applicable	Completed	-	United States, North Carolina ... More >> Glaxo Wellcome Inc Research Triangle Park, North Carolina, United States, 277093398 Less <<
NCT00046176	Infection, Human Immunodeficie... More >>ncy Virus I HIV Infection Less <<	Phase 3	Completed	-	-
NCT01389063	Endothelial Dysfunction	Phase 4	Unknown	October 2014	Netherlands ... More >> University Medical Center Utrecht Recruiting Utrecht, Netherlands, 3584CX Contact: Steven FL van Lelyveld, MD s.f.l.vanlelyveld@umcutrecht.nl Less <<
NCT00021489	HIV Infections	Phase 2	Withdrawn	-	-
NCT00335270	HIV	Phase 4	Completed	-	United States, Florida ... More >> University of Miami School of Medicine Miami, Florida, United States, 33136 Less <<
NCT00002205	HIV Infections	Not Applicable	Completed	-	United States, North Carolina ... More >> Glaxo Wellcome Inc Research Triangle Park, North Carolina, United States, 277093398 Less <<
NCT00244712	HIV Infection	Phase 4	Completed	-	-
NCT01263015	Infection, Human Immunodeficie... More >>ncy Virus I Less <<	Phase 3	Completed	-	-
NCT00270556	HIV	Phase 2	Completed	-	-
NCT01622790	Infection, Human Immunodeficie... More >>ncy Virus Less <<	Phase 1	Completed	-	United States, Kansas ... More >> GSK Investigational Site Overland Park, Kansas, United States, 66211 Less <<
NCT00440947	Infection, Human Immunodeficie... More >>ncy Virus I HIV Infection Less <<	Phase 3	Completed	-	-
NCT00244712	-		Completed	-	-
NCT00192634	HIV Infections	Phase 4	Completed	-	Australia, New South Wales ... More >> Holdsworth House General Practice - Byron Bay Byron Bay, New South Wales, Australia, 2481 Lismore Sexual Health Clinic - Northen Rivers Area Health Service Lismore, New South Wales, Australia, 2480 John Hunter Hospital Newcastle, New South Wales, Australia, 2304 407 Doctors Sydney, New South Wales, Australia, 2010 Albion Street Centre Sydney, New South Wales, Australia, 2010 Holdsworth House General Practice Sydney, New South Wales, Australia, 2010 St. Vincent's Hospital Sydney, New South Wales, Australia, 2010 Taylor Square Private Clinic Sydney, New South Wales, Australia, 2010 Prince of Wales Hospital Sydney, New South Wales, Australia, 2031 Clinic 16, Royal North Shore Hospital Sydney, New South Wales, Australia, 2065 Burwood Road Practice Sydney, New South Wales, Australia, 2134 Westmead Hospital Sydney, New South Wales, Australia, 2145 Liverpool Health Service Sydney, New South Wales, Australia, 2170 Australia, Queensland QLD Health - AIDS Medical Unit Brisbane, Queensland, Australia, 4002 Royal Brisbane and Women's Hospital Brisbane, Queensland, Australia, 4029 Gladstone Road Medical Centre Brisbane, Queensland, Australia, 4101 Doll's House Clinic - Cairns Base Hospital Cairns, Queensland, Australia, 4870 Gold Coast Sexual Health Clinic Miami, Queensland, Australia, 4220 Clinic 87, Nambour Hospital Nambour, Queensland, Australia, 4560 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 The Care and Prevention Programme - Adelaide University Adelaide, South Australia, Australia, 5000 Flinders Medical Centre Adelaide, South Australia, Australia, 5042 Australia, Victoria The Alfred Hospital Melbourne, Victoria, Australia, 3004 Carlton Clinic Melbourne, Victoria, Australia, 3053 Melbourne Sexual Health Centre Melbourne, Victoria, Australia, 3053 Prahran Market Clinic Melbourne, Victoria, Australia, 3141 Monash Medical Centre Melbourne, Victoria, Australia, 3168 The Centre Clinic Melbourne, Victoria, Australia, 3182 Royal Melbourne Hospital Melbourne, Victoria, Australia, 3403 Australia, Western Australia Fremantle Hospital Fremantle, Western Australia, Australia, 6160 Royal Perth Hospital Perth, Western Australia, Australia, 6000 Less <<
NCT01059422	HIV Infections ... More >> Tuberculosis Less <<	Phase 4	Unknown	-	Russian Federation ... More >> Central Research Institute of Epidemiology Recruiting Moscow, Russian Federation, 111123 Contact: Alexey V. Kravtchenko, PhD +74953660518 alexey-kravtchenko@yandex.ru Sub-Investigator: Alexey V. Kravtchenko, PhD Less <<
NCT00002141	HIV Infections	Phase 1	Completed	-	United States, District of Col... More >>umbia Georgetown Univ Med Ctr Washington, District of Columbia, United States, 20007 United States, Kansas Ctr for Phase I Research Wichita, Kansas, United States, 67214 Less <<
NCT00087945	HIV Infections	Not Applicable	Completed	-	United States, California ... More >> Usc La Nichd Crs Alhambra, California, United States, 91803 Children's Hospital of Los Angeles NICHD CRS Los Angeles, California, United States, 90027 UCSD Mother-Child-Adolescent Program CRS San Diego, California, United States, 92103 United States, District of Columbia Children's National Med. Ctr. Washington DC NICHD CRS Washington, District of Columbia, United States, 20010 Children's National Med. Ctr., ACTU Washington, District of Columbia, United States, 20010 United States, Florida Univ. of Florida Jacksonville NICHD CRS Jacksonville, Florida, United States, 32209 USF - Tampa NICHD CRS Tampa, Florida, United States, 33606 United States, Georgia Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases Augusta, Georgia, United States, 30912 United States, Illinois Chicago Children's CRS Chicago, Illinois, United States, 60614 United States, Louisiana Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States, 70112 United States, Massachusetts HMS - Children's Hosp. Boston, Div. of Infectious Diseases Boston, Massachusetts, United States, 02115 Baystate Health, Baystate Med. Ctr. Springfield, Massachusetts, United States, 01199 United States, Michigan Children's Hospital of Michigan NICHD CRS Detroit, Michigan, United States, 48201 United States, New Jersey UMDNJ - Robert Wood Johnson Med. School, Div. of Allergy, Immunology & Infectious Diseases New Brunswick, New Jersey, United States, 08901 Rutgers - New Jersey Medical School CRS Newark, New Jersey, United States, 07103 United States, New York Bronx-Lebanon Hosp. IMPAACT CRS Bronx, New York, United States, 10457 Columbia IMPAACT CRS New York, New York, United States, 10032 United States, North Carolina UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases Chapel Hill, North Carolina, United States, 27599 United States, Tennessee St. Jude/UTHSC CRS Memphis, Tennessee, United States, 38105 Puerto Rico San Juan City Hosp. PR NICHD CRS San Juan, Puerto Rico, 00936 Less <<
NCT01263015	-		Completed	-	-
NCT00647244	HIV Infections	Phase 4	Completed	-	Denmark ... More >> Aarhus University Hospital Århus N, Denmark, 8200 Less <<
NCT00440947	-		Completed	-	-
NCT00740064	HIV Infections	Phase 4	Unknown	November 2009	United States, Arizona ... More >> Spectrum Medical Group Phoenix, Arizona, United States, 85012 United States, Colorado Denver Infectious Disease Consultants, PLLC Denver, Colorado, United States, 80220 United States, New Mexico Southwest CARE Center Santa Fe, New Mexico, United States, 87505-4765 Less <<
NCT02159599	HIV Infection	Phase 4	Completed	-	Spain ... More >> Hospital Universitario de Bellvitge Hospitalet de Llobregat, Barcelona, Spain Hospital General Universitario de Alicante Alicante, Spain Hospital Universitario Germans Trias i Pujol Badalona, Spain Hospital Clinic Barcelona, Spain Hospital de La Santa Creu I Sant Pau Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Universitario Vall D'Hebron Barcelona, Spain Hospital Universitario Reina Sofía Córdoba, Spain Hospital Universitario Virgen de las Nieves Granada, Spain Complejo Hospitalario de Huelva Huelva, Spain Hospital 12 de Octubre Madrid, Spain Hospital Universitario Clínico San Carlos Madrid, Spain Hospital Universitario Fundación Alcorcón Madrid, Spain Hospital Universitario Gregorio Marañón Madrid, Spain Hospital universitario Infanta Leonor Madrid, Spain Hospital Universitario La Paz Madrid, Spain Hospital Universitario Príncipe de Asturias Madrid, Spain Hospital de Mataró Mataró, Spain Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital Universitario Donostia San Sebastián, Spain Hospital Universitario Miguel Servet Zaragoza, Spain Less <<
NCT00011479	HIV Infections	Phase 1	Completed	-	-
NCT00214890	HIV Infections	Phase 2	Completed	-	United States, California ... More >> UCI Irvine, California, United States, 92668 USC Los Angeles, California, United States, 90033 University of California San Diego San Diego, California, United States, 92103 Santa Clara Valley Medical Center San Jose, California, United States, 95128 Harbor-UCLA Medical Center Torrance, California, United States, 90502 Less <<
NCT00851630	-		Completed	-	-
NCT00958100	HIV/AIDS Anti... More >>retroviral Therapy HIV Infections Less <<	Phase 2	Completed	-	Italy ... More >> Policlinico A. Gemelli Rome, Italy, 00168 Less <<
NCT03760458	HIV Infections	Phase 1 Phase 2	Not yet recruiting	August 2023	United States, Illinois ... More >> Lurie Children's Hospital of Chicago (LCH) CRS Not yet recruiting Chicago, Illinois, United States, 60614-3393 Contact: Margaret Ann Sanders, M.P.H. 312-227-8275 msanders@luriechildrens.org Less <<
NCT00851630	HIV Tuberculo... More >>sis Less <<	Phase 4	Completed	-	Tanzania ... More >> Kilimanjaro Christian Medical Centre Moshi, Tanzania Less <<
NCT00340080	HIV Infection	PHASE4	COMPLETED	-	GSK Investigational Site, Darl... More >>inghurst, New South Wales, 2010, Australia\|GSK Investigational Site, Miami, Queensland, 4220, Australia\|GSK Investigational Site, Graz, A-8020, Austria\|GSK Investigational Site, Innsbruck, A-6020, Austria\|GSK Investigational Site, Linz, A-4020, Austria\|GSK Investigational Site, Salzburg, A-5020, Austria\|GSK Investigational Site, Vienna, A-1090, Austria\|GSK Investigational Site, Brugge, 8000, Belgium\|GSK Investigational Site, Brussels, 1070, Belgium\|GSK Investigational Site, Brussel, 1090, Belgium\|GSK Investigational Site, Bruxelles, 1000, Belgium\|GSK Investigational Site, Bruxelles, 1050, Belgium\|GSK Investigational Site, Gent, 9000, Belgium\|GSK Investigational Site, Leuven, 3000, Belgium\|GSK Investigational Site, Liege, 4000, Belgium\|GSK Investigational Site, Aix En Provence, 13616, France\|GSK Investigational Site, Amiens, 80054, France\|GSK Investigational Site, Angers, 49000, France\|GSK Investigational Site, Annecy, 74011, France\|GSK Investigational Site, Avignon, 84000, France\|GSK Investigational Site, Besan?on, 25030, France\|GSK Investigational Site, Bobigny Cedex, 93009, France\|GSK Investigational Site, Bondy, 93143, France\|GSK Investigational Site, Bordeaux Cedex, 33076, France\|GSK Investigational Site, Bordeaux, 33000, France\|GSK Investigational Site, Caen, 14000, France\|GSK Investigational Site, Cannes, 06401, France\|GSK Investigational Site, Clermont-Ferrand, 63058, France\|GSK Investigational Site, Corbeil Essonnes Cedex, 91106, France\|GSK Investigational Site, Créteil, 94010, France\|GSK Investigational Site, Dijon, 21079, France\|GSK Investigational Site, Fréjus, 83608, France\|GSK Investigational Site, Grenoble, 38043, France\|GSK Investigational Site, La Roche Sur Yon Cedex 9, 85025, France\|GSK Investigational Site, La Rochelle, 17019, France\|GSK Investigational Site, Le Kremlin Bicêtre Cedex, 94275, France\|GSK Investigational Site, Levallois-Perret, 92300, France\|GSK Investigational Site, Lyon Cedex 03, 69437, France\|GSK Investigational Site, Marseille Cedex 08, 13285, France\|GSK Investigational Site, Marseille, 13005, France\|GSK Investigational Site, Marseille, 13006, France\|GSK Investigational Site, Marseille, 13274, France\|GSK Investigational Site, Marseille, 13915, France\|GSK Investigational Site, Metz, 57000, France\|GSK Investigational Site, Montpellier Cedex 5, 34295, France\|GSK Investigational Site, Mulhouse, 68000, France\|GSK Investigational Site, Nantes, 44093, France\|GSK Investigational Site, Nice, 06202, France\|GSK Investigational Site, Nimes Cedex 9, 30029, France\|GSK Investigational Site, Niort, 79021, France\|GSK Investigational Site, Orléans, 45100, France\|GSK Investigational Site, Paris Cedex 10, 75475, France\|GSK Investigational Site, Paris Cedex 13, 75651, France\|GSK Investigational Site, Paris Cedex 14, 75679, France\|GSK Investigational Site, Paris Cedex 20, 75970, France\|GSK Investigational Site, Paris, 75014, France\|GSK Investigational Site, Paris, 75018, France\|GSK Investigational Site, Perpignan, 66046, France\|GSK Investigational Site, Poitiers, 86021, France\|GSK Investigational Site, Quimper, 29107, France\|GSK Investigational Site, Reims, 51092, France\|GSK Investigational Site, Rennes Cedex 09, 35033, France\|GSK Investigational Site, Rouen, 76030, France\|GSK Investigational Site, Saint Brieuc, 22023, France\|GSK Investigational Site, Saint Denis Cedex 01, 93205, France\|GSK Investigational Site, Saint-Etienne, 42055, France\|GSK Investigational Site, Saint-Germain-en-Laye Cedex, 78100, France\|GSK Investigational Site, Strasbourg, 67000, France\|GSK Investigational Site, Toulouse, 31059, France\|GSK Investigational Site, Tourcoing, 59208, France\|GSK Investigational Site, Tours, 37044, France\|GSK Investigational Site, Troyes, 10003, France\|GSK Investigational Site, Valence, 26953, France\|GSK Investigational Site, Valenciennes, 59300, France\|GSK Investigational Site, Villejuif Cedex, 94804, France\|GSK Investigational Site, Freiburg, Baden-Wuerttemberg, 79098, Germany\|GSK Investigational Site, Stuttgart, Baden-Wuerttemberg, 70197, Germany\|GSK Investigational Site, Erlangen, Bayern, 91054, Germany\|GSK Investigational Site, Fuerth, Bayern, 90762, Germany\|GSK Investigational Site, Muenchen, Bayern, 80331, Germany\|GSK Investigational Site, Muenchen, Bayern, 80335, Germany\|GSK Investigational Site, Muenchen, Bayern, 80801, Germany\|GSK Investigational Site, Wuerzburg, Bayern, 97080, Germany\|GSK Investigational Site, Frankfurt, Hessen, 60590, Germany\|GSK Investigational Site, Hannover, Niedersachsen, 30159, Germany\|GSK Investigational Site, Hannover, Niedersachsen, 30625, Germany\|GSK Investigational Site, Osnabrueck, Niedersachsen, 49090, Germany\|GSK Investigational Site, Bochum, Nordrhein-Westfalen, 44791, Germany\|GSK Investigational Site, Dortmund, Nordrhein-Westfalen, 44137, Germany\|GSK Investigational Site, Essen, Nordrhein-Westfalen, 45122, Germany\|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50937, Germany\|GSK Investigational Site, Muenster, Nordrhein-Westfalen, 48143, Germany\|GSK Investigational Site, Muenster, Nordrhein-Westfalen, 48149, Germany\|GSK Investigational Site, Mainz, Rheinland-Pfalz, 55116, Germany\|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, 39120, Germany\|GSK Investigational Site, Leipzig, Sachsen, 04170, Germany\|GSK Investigational Site, Kiel, Schleswig-Holstein, 24116, Germany\|GSK Investigational Site, Berlin, 13353, Germany\|GSK Investigational Site, Hamburg, 20095, Germany\|GSK Investigational Site, Hamburg, 20146, Germany\|GSK Investigational Site, Hamburg, 20246, Germany\|GSK Investigational Site, Dublin, 8, Ireland\|GSK Investigational Site, Kfar Saba, 44281, Israel\|GSK Investigational Site, Ramat Gan, 52621, Israel\|GSK Investigational Site, Rehovot, 76100, Israel\|GSK Investigational Site, Tel-Aviv, 64239, Israel\|GSK Investigational Site, Catanzaro, Calabria, 88100, Italy\|GSK Investigational Site, Napoli, Campania, 80131, Italy\|GSK Investigational Site, Salerno, Campania, 84131, Italy\|GSK Investigational Site, Bologna, Emilia-Romagna, 40133, Italy\|GSK Investigational Site, Bologna, Emilia-Romagna, 40138, Italy\|GSK Investigational Site, Ferrara, Emilia-Romagna, 44100, Italy\|GSK Investigational Site, Piacenza, Emilia-Romagna, 29100, Italy\|GSK Investigational Site, Rimini, Emilia-Romagna, 47900, Italy\|GSK Investigational Site, Latina, Lazio, 04100, Italy\|GSK Investigational Site, Roma, Lazio, 00161, Italy\|GSK Investigational Site, Roma, Lazio, 00185, Italy\|GSK Investigational Site, Genova, Liguria, 16132, Italy\|GSK Investigational Site, Sanremo (im), Liguria, 18032, Italy\|GSK Investigational Site, Bergamo, Lombardia, 24128, Italy\|GSK Investigational Site, Brescia, Lombardia, 25125, Italy\|GSK Investigational Site, Busto Arsizio (va), Lombardia, 21052, Italy\|GSK Investigational Site, Cuggiono (mi), Lombardia, 20012, Italy\|GSK Investigational Site, Milano, Lombardia, 20127, Italy\|GSK Investigational Site, Milano, Lombardia, 20142, Italy\|GSK Investigational Site, Milano, Lombardia, 20157, Italy\|GSK Investigational Site, Torrette Di Ancona (an), Marche, 60020, Italy\|GSK Investigational Site, Asti, Piemonte, 14100, Italy\|GSK Investigational Site, Pallanza (Verbania), Piemonte, 28921, Italy\|GSK Investigational Site, Torino, Piemonte, 10149, Italy\|GSK Investigational Site, Bari, Puglia, 70124, Italy\|GSK Investigational Site, Cagliari, Sardegna, 09121, Italy\|GSK Investigational Site, Sassari, Sardegna, 71000, Italy\|GSK Investigational Site, Catania, Sicilia, 95100, Italy\|GSK Investigational Site, Grosseto, Toscana, 58100, Italy\|GSK Investigational Site, Bolzano, Trentino-Alto Adige, 39100, Italy\|GSK Investigational Site, Padova, Veneto, 35128, Italy\|GSK Investigational Site, Treviso, Veneto, 31100, Italy\|GSK Investigational Site, Vicenza, Veneto, 36100, Italy\|GSK Investigational Site, Riga, LV1006, Latvia\|GSK Investigational Site, Alkmaar, 1815 JD, Netherlands\|GSK Investigational Site, Amsterdam, 1091 AC, Netherlands\|GSK Investigational Site, Arnhem, 6815 AD, Netherlands\|GSK Investigational Site, Den Haag, 2512 VA, Netherlands\|GSK Investigational Site, Den Haag, 2545 CH, Netherlands\|GSK Investigational Site, Enschede, 7511JX, Netherlands\|GSK Investigational Site, Groningen, 9713 GZ, Netherlands\|GSK Investigational Site, Nijmegen, 6525 GA, Netherlands\|GSK Investigational Site, Rotterdam, 3015 GD, Netherlands\|GSK Investigational Site, Rotterdam, 3078 HT, Netherlands\|GSK Investigational Site, Tilburg, 5022 GC, Netherlands\|GSK Investigational Site, Vlissingen, 4382 EE, Netherlands\|GSK Investigational Site, Zwolle, 8025 AB, Netherlands\|GSK Investigational Site, Fredrikstad, 1606, Norway\|GSK Investigational Site, Oslo, 0450, Norway\|GSK Investigational Site, Bydgoszcz, 85-030, Poland\|GSK Investigational Site, Chorzow, 41-500, Poland\|GSK Investigational Site, Szczecin, 71-455, Poland\|GSK Investigational Site, Warszawa, 01-201, Poland\|GSK Investigational Site, Almada, 2805 - 267, Portugal\|GSK Investigational Site, Amadora, 2720-276, Portugal\|GSK Investigational Site, Aveiro, 4814-501, Portugal\|GSK Investigational Site, Cascais, 2750, Portugal\|GSK Investigational Site, Lisboa, 1150-242, Portugal\|GSK Investigational Site, Monte Funchal, 9054-535, Portugal\|GSK Investigational Site, Ponta Delgada, 9500-270, Portugal\|GSK Investigational Site, Porto, 4369-004, Portugal\|GSK Investigational Site, Bucharest, 021105, Romania\|GSK Investigational Site, Constanta, 900709, Romania\|GSK Investigational Site, Iasi, 700116, Romania\|GSK Investigational Site, Barnaul, 656010, Russian Federation\|GSK Investigational Site, Belgorod, 308036, Russian Federation\|GSK Investigational Site, Krasnodar, 350015, Russian Federation\|GSK Investigational Site, Lipetsk, 398043, Russian Federation\|GSK Investigational Site, Moscow, 105275, Russian Federation\|GSK Investigational Site, Murmansk, 183001, Russian Federation\|GSK Investigational Site, N.Novgorod, 603005, Russian Federation\|GSK Investigational Site, Orel, 302040, Russian Federation\|GSK Investigational Site, Perm, 614990, Russian Federation\|GSK Investigational Site, Ryazan, 390046, Russian Federation\|GSK Investigational Site, Saint-Petersburg, Russian Federation\|GSK Investigational Site, Samara, Russian Federation\|GSK Investigational Site, Saratov, 410009, Russian Federation\|GSK Investigational Site, Smolensk, 214006, Russian Federation\|GSK Investigational Site, St. Petersburg, 196645, Russian Federation\|GSK Investigational Site, Volgograd, 400040, Russian Federation\|GSK Investigational Site, Ljubljana, 1000, Slovenia\|GSK Investigational Site, Alcala de Henares, 28805, Spain\|GSK Investigational Site, Alicante, 03010, Spain\|GSK Investigational Site, Badalona, 08916, Spain\|GSK Investigational Site, Baracaldo/Vizcaya, 48903, Spain\|GSK Investigational Site, Barcelona, 08003, Spain\|GSK Investigational Site, Barcelona, 08025, Spain\|GSK Investigational Site, Barcelona, 08035, Spain\|GSK Investigational Site, Barcelona, 08907, Spain\|GSK Investigational Site, Barcelona, 8400, Spain\|GSK Investigational Site, Bilbao, 48013, Spain\|GSK Investigational Site, Calella, 08370, Spain\|GSK Investigational Site, Córdoba, 14004, Spain\|GSK Investigational Site, Elche (Alicante), 03202, Spain\|GSK Investigational Site, Granada, 18003, Spain\|GSK Investigational Site, La Coru?a, 15006, Spain\|GSK Investigational Site, Madrid, 28007, Spain\|GSK Investigational Site, Madrid, 28029, Spain\|GSK Investigational Site, Madrid, 28034, Spain\|GSK Investigational Site, Madrid, 28040, Spain\|GSK Investigational Site, Madrid, 28046, Spain\|GSK Investigational Site, Madrid, Spain\|GSK Investigational Site, Malaga, 29010, Spain\|GSK Investigational Site, Marid, 28040, Spain\|GSK Investigational Site, Mataro, 08034, Spain\|GSK Investigational Site, Oviedo, 33006, Spain\|GSK Investigational Site, Reus, 43201, Spain\|GSK Investigational Site, San Sebastián, 20014, Spain\|GSK Investigational Site, Santander, 39008, Spain\|GSK Investigational Site, Sevilla, 41013, Spain\|GSK Investigational Site, Sevilla, 41041, Spain\|GSK Investigational Site, Sevilla, 41071, Spain\|GSK Investigational Site, Tarragona, 43007, Spain\|GSK Investigational Site, Valencia, 46010, Spain\|GSK Investigational Site, Valencia, 46015, Spain\|GSK Investigational Site, Vigo ( Pontevedra), 36204, Spain\|GSK Investigational Site, Vitoria, 01009, Spain\|GSK Investigational Site, Basel, 4031, Switzerland\|GSK Investigational Site, Bruderholz, 4101, Switzerland\|GSK Investigational Site, La Chaux-de-Fonds, CH 2301, Switzerland\|GSK Investigational Site, Lausanne, 1004, Switzerland\|GSK Investigational Site, Lausanne, 1011, Switzerland\|GSK Investigational Site, Lugano, 6900, Switzerland\|GSK Investigational Site, St Gallen, 9007, Switzerland\|GSK Investigational Site, Zurich, 8038, Switzerland\|GSK Investigational Site, Derby, Derbyshire, DE1 2QY, United Kingdom\|GSK Investigational Site, Manchester, Lancashire, M8 5RB, United Kingdom\|GSK Investigational Site, Woolwich, London, London, SE18 4QH, United Kingdom\|GSK Investigational Site, Nottingham, Nottinghamshire, NG5 1PB, United Kingdom\|GSK Investigational Site, Stoke-on-Trent, Staffordshire, ST4 7PA, United Kingdom\|GSK Investigational Site, Belfast, BT12 6BA, United Kingdom\|GSK Investigational Site, Birmingham, WS2 9PS, United Kingdom\|GSK Investigational Site, Coventry, CV1 4FH, United Kingdom\|GSK Investigational Site, Dudley, Birmingham, DY1 4SE, United Kingdom\|GSK Investigational Site, East Yorkshire, HU16 5JQ, United Kingdom\|GSK Investigational Site, Farnworth, Bolton, BL4 0JR, United Kingdom\|GSK Investigational Site, Glasgow, G12 0YN, United Kingdom\|GSK Investigational Site, Gloucester, GL1 3NN, United Kingdom\|GSK Investigational Site, Leicester, LE1 5WW, United Kingdom\|GSK Investigational Site, London, N18 1QX, United Kingdom\|GSK Investigational Site, London, NW3 2QG, United Kingdom\|GSK Investigational Site, London, SE13 6LR, United Kingdom\|GSK Investigational Site, London, SW10 9TH, United Kingdom\|GSK Investigational Site, London, SW17 0QT, United Kingdom\|GSK Investigational Site, London, W2 1NY, United Kingdom\|GSK Investigational Site, Middlesborough, TS4 3BW, United Kingdom\|GSK Investigational Site, Plaistow, London, E13 8SL, United Kingdom\|GSK Investigational Site, Sheffield, S10 2JF, United Kingdom Less <<
NCT01366547	Healthy Subjects ... More >> Infection, Human Immunodeficiency Virus Less <<	Phase 1	Completed	-	United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT03081572	-		Recruiting	December 2019	United States, California ... More >> Clinical AIDS Research and Education Center Recruiting Los Angeles, California, United States, 90025 Contact: Janine Trevillyan, MBBS PhD 310-666-8453 jtrevillyan@mednet.ucla.edu Less <<
NCT02384395	HIV Acute HIV... More >> Infection Less <<	Not Applicable	Recruiting	July 2021	United States, North Carolina ... More >> University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Duke University Health System Recruiting Durham, North Carolina, United States, 27710 Contact: Kara McGee, MSPH, PA-C 919-668-0242 kara.mcgee@duke.edu Principal Investigator: Mehri McKellar, MD Less <<
NCT01900106	HIV Infection	Phase 3	Unknown	December 2016	Italy ... More >> University of Modena and Reggio Emilia Recruiting Modena, Italy, 41124 Contact: Cristina - Mussini, Professor +390594222466 cristina.mussini@unimore.it Less <<
NCT00320307	HIV Infection	Phase 1	Completed	-	United Kingdom ... More >> GSK Investigational Site London, United Kingdom, SW10 9TH Less <<
NCT02067767	HIV-1 Infection	Phase 2	Completed	-	France ... More >> La Roche-sur-Yon Hospital La Roche-sur-Yon, France Nantes University Hospital Nantes, France Less <<
NCT00314626	HIV Infections	Phase 3	Completed	-	Spain ... More >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Hospital de Mataró Mataro, Barcelona, Spain, 08304 Hospital de Aranzazu San Sebastian, Guipuzcoa, Spain, 20014 Hospital San Millan de Logroño Logroño, La Rioja, Spain, 26001 Hospital Principe de Asturias Alcala de Henares, Madrid, Spain, 28005 Hospital de Móstoles Mostoles, Madrid, Spain, 28935 Hospital Costa del Sol Marbella, Málaga, Spain, 29600 Hospital Universitario de Canarias La Laguna, Santa Cruz de Tenerife, Spain, 38320 Hospital de la Vall d'Hebron Barcelona, Spain, 08035 Hospital Virgen de las Nieves Granada, Spain, 18014 Hospital Arnau de Vilanova de Lleida Lleida, Spain, 25198 Hospital Severo Ochoa Leganés Madrid, Spain, 28911 Hospital Cristal-Piñor Ourense, Spain, 32005 Hospital Santa María Nai Ourense, Spain, 32005 Hospital de Navarra Pamplona, Spain, 31008 Hospital General de Valencia Valencia, Spain, 46014 Less <<
NCT01052701	Hepatitis C H... More >>IV Less <<	Phase 1	Completed	-	United States, Maryland ... More >> Johns Hopkins Drug Development Unit Baltimore, Maryland, United States, 21287 Less <<
NCT02182765	HIV Infections	Phase 1	Terminated	-	-
NCT02957864	Renal Insufficiency,Chronic ... More >> Hiv Therapeutic Agent Toxicity Less <<	Phase 4	Recruiting	February 2020	Netherlands ... More >> Ziekenhuis Rijnstate Recruiting Arnhem, Gelderland, Netherlands Contact: Marc Claassen, PhD MC Slotervaart Recruiting Amsterdam, Netherlands, 1066EC Contact: Saskia Vrouenraets, MD, PhD 0205129333 saskia.vrouenraets@slz.nl OLVG Not yet recruiting Amsterdam, Netherlands, 1091AC Contact: Guido van den Berk, MD, PhD 0205999111 g.e.l.vandenberk@olvg.nl Erasmus MC Recruiting Rotterdam, Netherlands, 3000CA Contact: ingeborg wijting, MD 0031107040704 i.wijting@erasmusmc.nl Contact: bart rijnders, MD PhD 0031107033510 b.rijnders@erasmusmc.nl Maasstad ziekenhuis Recruiting Rotterdam, Netherlands, 3079DZ Contact: Anna Roukens, MD, PhD 0102911911 roukensa@maasstadziekenhuis.nl Less <<
NCT01656122	HIV	Phase 2 Phase 3	Completed	-	Thailand ... More >> The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT) Bangkok, Thailand, 10330 Less <<
NCT01205243	-		Completed	-	Korea, Republic of ... More >> GSK Investigational Site Incheon, Korea, Republic of, 400-711 Less <<
NCT02659761	Human Immunodeficiency Virus	Phase 4	Recruiting	March 2019	Ireland ... More >> Mater Misericordiae University Hospital Recruiting Dublin, Ireland, 7 Contact: Willard Tinago, PhD wtinago@gmail.com Contact: Patrick WG Mallon, MB BCh, PhD, FRCPI paddy.mallon@ucd.ie Principal Investigator: Patrick Mallon, MB BCh, PhD, FRCPI Sub-Investigator: Gerard Sheehan, MB BCh BAO, FRCPI Sub-Investigator: John Lambert, MD, PhD Less <<
NCT01052701	-		Completed	-	-
NCT02093585	HIV	Phase 4	Completed	-	Denmark ... More >> Rigshospitalet, Klinik for Infektionsmedicin og Reumatologi, 8622 Copenhagen Ø, Copenhagen, Denmark, 2100 Less <<
NCT01220232	Healthy Volunteers	Phase 1	Completed	-	United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT02509195	HIV	Phase 4	Completed	-	United Kingdom ... More >> St Stephen's Centre, Chelsea & Westminster Hospital London, United Kingdom, SW10 9NH Less <<
NCT00765271	HIV	Phase 1	Completed	-	United Kingdom ... More >> Chelsea and Westminster Hospital London, United Kingdom, SW10 9TH Less <<
NCT02101216	Psoriasis	Phase 1	Completed	-	United States, Florida ... More >> Phase One Solutions Inc. Miami Gardens, Florida, United States, 33169 Less <<
NCT01973439	HIV Infection	Phase 1	Completed	-	France ... More >> Hôpital Port Royal Paris, France Hôpital Robert Debré Paris, France Germany Immundefekt-Ambulanz, Dr. von Haunersches Kinderspital Munich, Germany Italy Clinica Pediatrica, Università di Padova Padova, Italy, 35128 Spain Hospital Universitario Getafe, Spain Hospital 12 de Octubre Madrid, Spain Hospital Gregorio Maranon Madrid, Spain United Kingdom Birmingham Heartlands Hospital Birmingham, United Kingdom Evelina Children's Hospital London, United Kingdom St. Mary's Hospital London, United Kingdom Less <<
NCT01886638	HIV\|Cardiovascular Disease	PHASE4	COMPLETED	2025-10-14	Alfred Health, Melbourne, Vict... More >>oria, 3004, Australia Less <<
NCT01973439	-		Completed	-	-
NCT01153217	HIV	Phase 3	Completed	-	Spain ... More >> Lluita contra la SIDA Foundation Badalona, Barcelona, Spain, 08916 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08041 Less <<
NCT01213316	-		Completed	-	-
NCT01213316	-		Completed	-	-
NCT00537394	HIV Infections	Phase 3	Completed	-	-
NCT00537394	-		Completed	-	-
NCT00197145	Infection, Human Immunodeficie... More >>ncy Virus I Less <<	Phase 3	Terminated	-	-
NCT02229760	HIV Infections	Phase 1 Phase 2	Terminated	-	-
NCT01227824	Infection, Human Immunodeficie... More >>ncy Virus I Less <<	Phase 3	Completed	-	-
NCT00197145	-		Terminated	-	-
NCT02556268	HIV-DDI	Phase 1	Completed	-	United States, Florida ... More >> Orlando, Florida, United States, 32803 United States, Massachusetts Boston, Massachusetts, United States, 02118 Less <<
NCT01363011	Acquired Immunodeficiency Synd... More >>rome HIV Infections Less <<	Phase 3	Completed	-	-
NCT00065741	HIV Seronegativity	Phase 1	Completed	-	United States, North Carolina ... More >> General Clinical Research Center, Univiversity Of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00708162	HIV Infection	Phase 3	Completed	-	-
NCT01227824	-		Completed	-	-
NCT00043888	HIV Infections	Phase 3	Completed	-	United States, Arkansas ... More >> GSK Clinical Trials Call Center Little Rock, Arkansas, United States, 72205 United States, California GSK Clinical Trials Call Center Long Beach, California, United States, 90813 GSK Clinical Trials Call Center Newport Beach, California, United States, 92663 GSK Clinical Trials Call Center San Diego, California, United States, 92101 United States, Colorado GSK Clinical Trials Call Center Denver, Colorado, United States, 80220 United States, District of Columbia GSK Clinical Trials Call Center Washington, District of Columbia, United States, 20036 United States, Florida GSK Clinical Trials Call Center Altamonte Springs, Florida, United States, 32701 GSK Clinical Trials Call Center Fort Lauderdale, Florida, United States, 33308 GSK Clinical Trials Call Center Fort Lauderdale, Florida, United States, 33316 GSK Clinical Trials Call Center Fort Lauderdale, Florida, United States, 33334 United States, Georgia GSK Clinical Trials Call Center Atlanta, Georgia, United States, 30339 United States, North Carolina GSK Clinical Trials Call Center Greenville, North Carolina, United States, 27858 United States, Pennsylvania GSK Clinical Trials Call Center Philadelphia, Pennsylvania, United States, 19107 France GSK Clinical Trials Call Center Lyon, France, 69437 GSK Clinical Trials Call Center Paris, France, 75475 GSK Clinical Trials Call Center Paris, France, 75679 United Kingdom GSK Clinical Trials Call Center London, United Kingdom, SE5 9RS GSK Clinical Trials Call Center Manchester, United Kingdom, M8 6RL Less <<
NCT01605084	HIV	Phase 3	Withdrawn	August 2014	United States, Arizona ... More >> Southwest Center For Hiv/Aids Phoenix, Arizona, United States, 85006 United States, Arkansas Health For Life Clinic Pllc Little Rock, Arkansas, United States, 72207 United States, California Uc Davis Medical Center Sacramento, California, United States, 95817 Metropolis Medical Pc San Francisco, California, United States, 94109 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202 United States, Michigan Be Well Medical Center Berkley, Michigan, United States, 48072 United States, Missouri Southampton Health Center St Louis, Missouri, United States, 63139 United States, New Jersey I.D. Care Associates Hillsborourgh, New Jersey, United States, 08844 Saint Michael'S Medical Center Newark, New Jersey, United States, 07102 United States, New York James J Peters VAMC Bronx, New York, United States, 10468 Infectious Disease Clinic & AI Bronx, New York, United States Less <<
NCT00850395	-		Completed	-	-
NCT01363011	-		Completed	-	-
NCT00708162	-		Completed	-	-
NCT01252940	HIV-1 Infection	Phase 3	Completed	-	-
NCT02157311	HIV-1 Infection	Phase 3	Completed	-	France ... More >> Hôpital Meynard Fort-de-france, Martinique, France, 97261 Hôpital Avicenne Bobigny, France, 93000 CHU Côte de Nacre Caen, France, 14033 Centre Hospitalier Sud Francilien Corbeil Essonnes, France, 91100 Hôpital Le Bocage Dijon, France, 21079 Hôpital Raymond Poincaré Garches, France, 92380 Hôpital Bicêtre Kremlin Bicetre, France, 94275 Hôpital Gui de Chauliac Montpellier, France, 34295 Hôpital Saint-Antoine Paris, France, 75012 Hôpital Pitié-Salpêtrière Paris, France, 75013 Hôpital Européen Georges Pompidou Paris, France, 75015 Hôpital Necker Paris, France, 75015 Hôpital Bichat Paris, France, 75018 Hôpital Tenon Paris, France, 75020 Hôpital Foch Suresnes, France, 92151 Hôpital Purpan Toulouse, France, 31059 Hôpital Bretonneau Tours, France, 37044 Less <<
NCT01252940	-		Completed	-	-
NCT00850395	-		Completed	-	-
NCT02275780	HIV-1	Phase 3	Active, not recruiting	June 23, 2021	-
NCT02354053	HIV Infections	Phase 4	Recruiting	January 2019	Canada, Quebec ... More >> Chronic Viral Illness Service Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Natacha Cotta-Grand, PhD natacha.cotta-grand@muhc.mcgill.ca Principal Investigator: Marina Klein, MD Sub-Investigator: Bertrand Lebouché, MD Sub-Investigator: Joe Cox, MD Sub-Investigator: Jean-Pierre Routy, MD Sub-Investigator: Cecilia Costiniuk, MD Sub-Investigator: Alexandra de Pokomandy, MD Less <<
NCT01637259	Proteinuria H... More >>IV Less <<	Phase 4	Completed	-	Argentina ... More >> Hospital Italiano de Buenos Aires Buenos Aires, Ciudad de Buenos Aires, Argentina, C1181ACH Hospital General de Agudos J M Ramos Mejia Buenos Aires, Ciudad de Buenos Aires, Argentina, C1221ADC Fundación IDEAA Buenos Aires, Ciudad de Buenos Aires, Argentina, C1405CKC Australia, New South Wales St. Vincent's Hospital Sydney, New South Wales, Australia, 2010 Australia, Queensland Brisbane Sexual Health and HIV Service Brisbane, Queensland, Australia, 4000 Canada, Alberta Southern Alberta Clinic Calgary, Alberta, Canada, T2R OX7 Canada, Ontario University Health Network - Toronto General Hospital Toronto, Ontario, Canada, M5G 2N2 Canada, Quebec Clinic Opus/Lori Montreal, Quebec, Canada, H3A 1T1 Germany Klinikum der Universitat Zu Koln Cologne, Germany, 50937 Universitätsklinikum Düsseldorf, Klinik für Gastroenterologie, Hepatologie und Infektiologie, MX-Ambulanz Dusseldorf, Germany, 40225 Japan Nagoya Medical Center Nagoya, Japan, 460-0001 Mexico Instituto Nacional de Ciencias Medicas y Nutriciòn Salvador Zubiran Mexico City, Tlalpan DF, Mexico, 14000 Thailand Chulalongkorn University Hospital Bangkok, Thailand, 10330 United Kingdom Western General Hospital Edinburgh, Lothian, United Kingdom Brighton & Sussex University NHS Trust Brighton, Sussex, United Kingdom Less <<
NCT02949388	Chronic Stable Plaque Psoriasi... More >>s Less <<	Phase 2	Completed	-	-
NCT01440569	Acquired Immunodeficiency Synd... More >>rome HIV Infections Less <<	Phase 3	Completed	-	-
NCT00000919	HIV Infections	Not Applicable	Completed	-	-
NCT02275780	-		Active, not recruiting	-	-
NCT03631732	HIV-1 Infection	Phase 3	Recruiting	August 2020	-
NCT01440569	-		Completed	-	-
NCT01637233	-		Completed	-	Argentina ... More >> Hospital Ramos Mejía Buenos Aires, Argentina, C1221ADC Fundación IDEAA Buenos Aires, Argentina, C1405CKC CAICI Rosario, Argentina Thailand Chulalongkorn University Hospital Bangkok, Thailand, 10330 United Kingdom Brighton & Sussex University NHS Trust Brighton, Sussex, United Kingdom, BN21ES, Imperial Healthcare, St. Mary's Hospital London, United Kingdom, W2 Less <<
NCT00001119	HIV Infections	Not Applicable	Completed	-	United States, California ... More >> San Francisco Dept of Hlth / AIDS Office San Francisco, California, United States, 94102 United States, Illinois Univ of Illinois Chicago / Howard Brown Hlth Ctr Chicago, Illinois, United States, 60612 United States, Massachusetts Fenway Community Health Ctr / HIVNET Boston, Massachusetts, United States, 02115 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Bronx-Lebanon Hosp Ctr Bronx, New York, United States, 10453 New York Univ Med Ctr New York, New York, United States, 10016 United States, Ohio Univ of Cincinnati Cincinnati, Ohio, United States, 452670405 United States, Rhode Island Mem Hosp of Rhode Island Pawtucket, Rhode Island, United States, 02860 United States, Washington Seattle HIVNET Seattle, Washington, United States, 98104 Univ of Washington Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Ctr Seattle, Washington, United States, 98109 Australia Saint Vincent's Hosp Med Centre Darlinghurst, Australia Less <<
NCT00000922	HIV Infections	Not Applicable	Completed	-	United States, California ... More >> Community Consortium / UCSF San Francisco, California, United States, 94110 United States, Colorado Denver CPCRA / Denver Public Hlth Denver, Colorado, United States, 802044507 United States, Connecticut Yale Univ School of Medicine / AIDS Program New Haven, Connecticut, United States, 06510 United States, District of Columbia Washington Reg AIDS Prog / Dept of Infect Dis Washington, District of Columbia, United States, 20422 United States, Georgia AIDS Research Consortium of Atlanta Atlanta, Georgia, United States, 303081962 United States, Illinois AIDS Research Alliance - Chicago Chicago, Illinois, United States, 60657 United States, Louisiana Louisiana Comm AIDS Rsch Prog / Tulane Univ Med New Orleans, Louisiana, United States, 70112 United States, Michigan Wayne State Univ - WSU/DMC / Univ Hlth Ctr Detroit, Michigan, United States, 48201 Henry Ford Hosp Detroit, Michigan, United States, 48202 United States, New Jersey Southern New Jersey AIDS Cln Trials / Dept of Med Camden, New Jersey, United States, 08103 North Jersey Community Research Initiative Newark, New Jersey, United States, 071032842 United States, New Mexico Partners in Research / New Mexico Albuquerque, New Mexico, United States, 87131 United States, New York Harlem AIDS Treatment Grp / Harlem Hosp Ctr New York, New York, United States, 10037 United States, Oregon The Research and Education Group Portland, Oregon, United States, 97210 United States, Pennsylvania Philadelphia FIGHT Philadelphia, Pennsylvania, United States, 19107 United States, Texas Univ TX Health Science Ctr Houston, Texas, United States, 77030 United States, Virginia Richmond AIDS Consortium / Div of Infect Diseases Richmond, Virginia, United States, 232980049 Less <<
NCT01048671	-		Completed	-	-
NCT02924389	HIV	Not Applicable	Recruiting	June 2020	United States, Georgia ... More >> Grady Health System Recruiting Atlanta, Georgia, United States, 30303 Contact: Cecile Lahiri, MD 404-616-6306 cdelill@emory.edu Ponce De Leon Center Recruiting Atlanta, Georgia, United States, 30308 Contact: Cecile Lahiri, MD 404-616-6306 cdelill@emory.edu Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Cecile Lahiri, MD 404-616-6306 cdelill@emory.edu Less <<
NCT00102206	HIV Infections	Phase 2	Completed	-	United States, Illinois ... More >> Chicago Children's CRS Chicago, Illinois, United States, 60614 United States, New York Columbia IMPAACT CRS New York, New York, United States SUNY Stony Brook NICHD CRS Stony Brook, New York, United States, 11794-8111 United States, North Carolina DUMC Ped. CRS Durham, North Carolina, United States, 27710 Less <<
NCT00039741	HIV Infections	Phase 2 Phase 3	Completed	-	-
NCT03447873	HIV Infections	Phase 4	Recruiting	June 1, 2020	Spain ... More >> Virgen del Rocio University Hospital Recruiting Sevilla, Spain, 41013 Contact: Luis F Lopez-Cortes, MD, PhD 34-955012011 luisfernando@lopezcortes.net Contact: Alicia Gutierrez-Valencia, PhD 34-955923081 alicia.gutierrez.valencia@gmail.com Less <<
NCT00039741	-		Completed	-	-
NCT02486133	HIV-Infection	Phase 3	Active, not recruiting	December 2018	Germany ... More >> Klinikum rechts der Isar Munich, Germany, 81675 Less <<
NCT00013520	HIV Infections	Phase 3	Completed	-	-
NCT01928407	HIV-1 Infection ... More >> Immunosuppression-related Infectious Disease Less <<	Phase 4	Completed	-	France ... More >> Hopital Zobda Quitman Fort De France, Martinique, France, 97261 Centre Hospitalier D'Argenteuil Argenteuil, France, 95107 Hopital Saint-Jacques Besancon, France, 25000 Hopital Avicenne Bobigny, France, 93000 Hopital Jean Verdier Bondy, France, 93143 Hopital Saint-Andre Bordeaux, France, 33075 Chu Cote de Nacre Caen, France, 14033 Hopital Louis Mourier Colombes, France, 92700 Hopital Le Bocage Dijon, France, 21034 Hopital Raymond Poincare Garches, France, 92380 C.H.D de Vendee La Roche Sur Yon, France, 85925 Hopital Dupuytren Limoges, France, 87000 Hopital Sainte-Marguerite Marseille, France, 13274 Centre Hospitalier de Melun Melun, France, 77011 Hopital L'Archet Nice, France, 06202 Hopital Lariboisiere Paris, France, 75010 Hopital Saint Antoine Paris, France, 75012 Hopital Pitie-Salpetriere Paris, France, 75013 Hopital Necker Paris, France, 75015 Hopital Bichat Paris, France, 75018 Hopital Tenon Paris, France, 75020 Hopital Pitie-Salpetriere Paris, France, 75651 Hopital Cochin Paris, France, 75674 Hopital Europeen Georges Pompidou Paris, France, 75908 Hopital Saint-Jean Roussillon Perpignan, France, 66046 Hopital Rene Dubos Pontoise, France, 95303 C.H.R.A Pringy, France, 74374 Hopital Civil Strasbourg, France, 67000 Hopital Gustave Dron Tourcoing, France, 59208 Hopital Bretonneau Tours, France, 37044 Less <<
NCT01448707	Human Immunodeficiency Virus (... More >>HIV) Infections Acquired Immunodeficiency Syndrome (AIDS) Virus Less <<	Phase 3	Completed	-	-
NCT01585753	-		Completed	-	Argentina ... More >> Hospital General de Agudos "Dr. José María Ramos Mejía" Buenos Aires, Argentina, C1221ADC Fundacion IDEAA Buenos Aires, Argentina, C1405CKC Hospital Italiano de Buenos Aires Buenos Aires, Argentina Australia, New South Wales St. Vincent's Hospital Sydney, New South Wales, Australia, 2010 Germany Johann Wolfgang Goethe-University Hospital, Medical HIVCENTER Frankfurt, Frankfurt am Main, Germany, 60590 Thailand Chulalongkorn University Hospital Bangkok, Thailand, 10330 Less <<
NCT00192660	HIV-Associated Lipodystrophy S... More >>yndrome Cardiovascular Disease Less <<	Phase 4	Completed	-	Australia, New South Wales ... More >> St. Vincent's Hospital Sydney, New South Wales, Australia, 2010 Less <<
NCT00978068	Malaria HIV I... More >>nfections Less <<	Phase 3	Completed	-	Uganda ... More >> IDRC - Tororo Research Clinic Tororo, Uganda Less <<
NCT00006154	HIV Infections	Phase 3	Completed	-	Canada, British Columbia ... More >> Viridae Clinical Sciences / University of British Columbia Vancouver, British Columbia, Canada Canada, Quebec Centre de traitment d'immunodeficience Montreal, Quebec, Canada Centre Hospitalier de la Universite de Montreal (CHUM) Montreal, Quebec, Canada Institut Thoracique de Montreal Montreal, Quebec, Canada Less <<
NCT00537966	HIV Infections	Not Applicable	Recruiting	January 2025	Switzerland ... More >> University of Zurich Recruiting Zurich, Switzerland Contact: Huldrych. Günthard Huldrych.guenthard@usz.ch Less <<
NCT00433992	-		Completed	-	-
NCT00433992	-		Completed	-	United States, Ohio ... More >> Case School of Medicine Cleveland, Ohio, United States, 44106 Less <<
NCT01448707	-		Completed	-	-
NCT00427297	HIV Infections	Phase 3	Terminated(There is no longer ... More >>equipoise. DSMB recommended termination.) Less <<	-	Kenya ... More >> Kenyatta National Hospital, University of Nairobi Nairobi, Kenya Less <<
NCT00000872	HIV Infections	Phase 2	Completed	-	United States, Florida ... More >> Univ. of Florida College of Medicine-Dept of Peds, Div. of Immunology, Infectious Diseases & Allergy Gainesville, Florida, United States, 32209 United States, Louisiana Tulane/LSU Maternal/Child CRS New Orleans, Louisiana, United States, 701122699 United States, Maryland Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology Baltimore, Maryland, United States, 21201 Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases Baltimore, Maryland, United States, 212874933 United States, Massachusetts BMC, Div. of Ped Infectious Diseases Boston, Massachusetts, United States, 02118 Baystate Health, Baystate Med. Ctr. Springfield, Massachusetts, United States, 01199 WNE Maternal Pediatric Adolescent AIDS CRS Worcester, Massachusetts, United States, 016550001 United States, Michigan Univ. of Mississippi Med. Ctr Children's Hosp. Detroit, Michigan, United States United States, New York Nyu Ny Nichd Crs New York, New York, United States United States, Pennsylvania The Children's Hosp. of Philadelphia IMPAACT CRS Philadelphia, Pennsylvania, United States, 191044318 United States, Texas Texas Children's Hosp. CRS Houston, Texas, United States, 77030 United States, Virginia Children's Hosp. of the King's Daughters, Infectious Disease Norfolk, Virginia, United States, 23507 Less <<
NCT00051090	HIV Infections ... More >> Hepatitis B Less <<	Not Applicable	Withdrawn	-	-
NCT03256422	HIV Infections	Phase 3	Active, not recruiting	December 2020	-
NCT01048671	-		Completed	-	-
NCT00427297	-		Terminated(There is no longer ... More >>equipoise. DSMB recommended termination.) Less <<	-	-
NCT00031070	HIV Infections	Phase 2	Completed	-	United States, California ... More >> University of California , Davis Medical Center Sacramento, California, United States, 95814 United States, Florida University of Miami Miami, Florida, United States, 33136-1013 United States, Illinois Rush Presbyterian - Saint Luke's Med Ctr / Infect Dis Chicago, Illinois, United States, 606123832 Rush Presbyterian - Saint Luke's Med Ctr Chicago, Illinois, United States, 60612 United States, Indiana Indiana University Hospital Indianapolis, Indiana, United States, 46202-5250 United States, Maryland University of Maryland, Institute of Human Virology Baltimore, Maryland, United States, 21201 United States, Minnesota Univ of Minnesota Minneapolis, Minnesota, United States, 55455-0392 United States, Missouri Washington Univ (St. Louis) St. Louis, Missouri, United States, 63108 United States, North Carolina Univ of North Carolina Chapel Hill, North Carolina, United States, 27599-7215 Univ of North Carolina / Infectious Disease Division Chapel Hill, North Carolina, United States, 27599 United States, Ohio Case Western Reserve Univ Cleveland, Ohio, United States, 44106 MetroHealth Med Ctr Cleveland, Ohio, United States, 441091998 United States, Pennsylvania University of Pennsylvania, Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Univ of Texas Southwestern Med Ctr Dallas, Texas, United States, 75390 Univ of Texas, Southwestern Med Ctr of Dallas Dallas, Texas, United States, 75390 Less <<

CAS No. :	136470-78-5
Formula :	C₁₄H₁₈N₆O
M.W :	286.33
SMILES Code :	OC[C@@H]1C=C[C@H](N2C=NC3=C(NC4CC4)N=C(N)N=C23)C1
Synonyms :	1592U89
MDL No. :	MFCD00903850
InChI Key :	MCGSCOLBFJQGHM-SCZZXKLOSA-N
Pubchem ID :	441300

GHS Pictogram:
Signal Word:	Danger
Hazard Statements:	H361-H317-H334-H341
Precautionary Statements:	P501-P261-P202-P285-P201-P280-P272-P308+P313-P304+P341-P302+P352-P333+P313-P363-P405

BMR fibroblasts	4 μM		Abacavir reduced the formation of cytoplasmic RNA/DNA hybrids and rescued CCD in BMR cells.	PMC8488014
Jurkat cells	10 µg/mL	6 h	To test the effect of Abacavir on TCR recognition, results showed that Abacavir inhibited TCR interactions with their cognate ligands.	PMC8850454
A172	20 μM	72 h	Reduced HERV-K ENV protein expression and OCT4 expression	PMC10313366
GBM43	20 μM	72 h	Reduced HERV-K ENV protein expression and OCT4 expression	PMC10313366
GBM28	20 μM	72 h	Reduced HERV-K ENV protein expression and OCT4 expression	PMC10313366
Human astrocytes	3 μM	4 weeks	Long-term treatment resulted in a reduction in replicative capacity and an increase in SA β-gal activity.	PMC5581874
Human astrocytes	10 μM	1 week	HAART treatment induces cell cycle arrest, senescence-associated beta-galactosidase, and the cell cycle inhibitor p21.	PMC5581874

NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ mice	Orthotopic SHH/TP53-mut and Group 3 MB mouse model	Intraperitoneal	50 mg/kg	Daily for 14 consecutive days	The RT/DEC/ABC therapy inhibited tumor growth and enhanced mouse survival.	PMC8998934
NSG mice	HIV-1-infected humanized mouse model	Intramuscular injection	40 mg/kg	4 weeks	To evaluate the efficacy of Abacavir in combination with LASER ART and CRISPR-Cas9 for suppressing HIV-1 infection. Results showed that the combined treatment eliminated HIV-1 proviral DNA in 58% of infected animals.	PMC10175831
Nude mice	NIH III nude mice	Oral	1mg/mL	Continued for 8 weeks	Abacavir treatment significantly enhanced the proliferation of BMR cells in soft agar and promoted tumor formation.	PMC8488014
Nude mice	GBM xenograft model	Intracranial pump	12.3 mg/kg	Once daily for 4 weeks	Abacavir significantly prolonged survival in GBM xenograft mice	PMC10313366
Mice	EcoHIV-infected mice	Oral gavage	150 mg/kg	Once daily for 14 days	Inhibits all vDNA synthesis and consequently viral DNA integration and vRNA synthesis	PMC5991655

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

{[proInfo.proName]}

CAS No.: 136470-78-5

{[proInfo.proName]}

CAS No.: 136470-78-5

Alternative Products

Product Details of Abacavir

Safety of Abacavir

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed